TongDaiMDPhD

PubMed

• 2 citations
  Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
  Rachel Evans, Kelvin Lee, Paul K Wallace, Mary Reid, Jason Muhitch, Askia Dozier, Circe Mesa, Patricia L Luaces, Orestes Santos-Morales, Adrienne Groman, Carlos Cedeno...> ;Frontiers in Oncology. 2022 Jan 1
• 503 citations
  Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
  Dung T. Le, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Dirk Jäger, Hiroki Hara, Matthew Burge, Bert H. O'Neil, Petr Kavan, Takayuki Yoshino, Rosine Guimbaud, Hiroya Tan...> ;Journal of Clinical Oncology. 2020 Jan 1
• Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies.
  Hannah K Choe, Maria Teresa De Sancho, Sunnie S. Kim, Tong Dai, Manish A. Shah> ;Blood Coagulation & Fibrinolysis. 2018 Mar 1
• 33 citations
  Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis
  Kelsey A. Klute, Julianna Brouwer, Minaxi Jhawer, Hayley Sachs, Anatasia Gangadin, Allyson J. Ocean, Elizabeta C. Popa, Tong Dai, Guojiao Wu, Paul J. Christos, Manish ...> ;European Journal of Cancer. 2016 Aug 1
• 48 citations
  Radiation therapy and the abscopal effect: a concept comes of age
  John Ng, Tong Dai> ;Annals of Translational Medicine. 2016 Mar 1
• 16 citations
  Chemoradiation in oesophageal cancer.
  Tong Dai, Manish A. Shah> ;Best Practice & Research. Clinical Gastroenterology. 2015 Feb 1
• 10 citations
  The Role of 18 F-FDG PET Imaging in Upper Gastrointestinal Malignancies
  Tong Dai, Elizabeta C. Popa, Manish A. Shah> ;Current Treatment Options in Oncology. 2014 Jul 27
• 20 citations
  Ruxolitinib Withdrawal Syndrome Leading to Tumor Lysis
  Tong Dai, Ellen W. Friedman, Stefan K. Barta> ;Journal of Clinical Oncology. 2013 Oct 10
• 19 citations
  Interaction between Altered Insulin and Lipid Metabolism in CEACAM1-inactive Transgenic Mice
  Tong Dai, George A. Abou-Rjaily, Qusai Y. Al-Share, Yan Yang, Mats A. Fernström, Anthony M. DeAngelis, Abraham D. Lee, Lawrence Sweetman, Antonino Amato, Marzia Pasqua...> ;The Journal of Biological Chemistry. 2004 Oct 22
• Join now to see all

Journal Articles

• A phase 2, open-label, study of single agent pembrolizumab in treatment refractory mismatch repair deficient metastatic colorectal cancer: the KEYNOTE-164 study.  
  1. Le D; Kim, TW; Van Cutsem E; Geva R; Jaeger D; Hara H; Burge M; O’Neill B; Kavan P; Yoshino T; Guimbaud R; Taniguchi H; Elez E; Al-Batran SE; Boland PM; Crocenzi T;..., Journal of Clinical Oncology, 8/6/2019
• The Role of 18F-FDG PET Imaging in Upper Gastrointestinal Malignancies  
  Dai T, Popa E, Shah MA, Curr Treat Options Oncol, 7/27/2014
• Ruxolitinib Withdrawal Syndrome Leading to Tumor Lysis  
  Dai T, Friedman EW, and Barta SK, Journal of Clinical Oncology, 10/1/2013
• Mitomycin-Induced Interstitial Pneumonitis in a Patient with BRCA2 Associated Metastatic Pancreatic Carcinoma  
  Saif MW and Dai T, J Pancreas, 5/1/2010
• CEACAM1: A Link Between Insulin and Lipid Metabolism  
  Deangelis AM, Heinrich G, Dai T, Bowman TA, Patel PR, Jun Lee S, Hong EG, Young Jung D, Assmann A, Kulkarni RN, Kim JK, Najjar SM, Diabetes, 9/1/2008
• Insulin acutely decreases hepatic fatty acid synthase activity  
  Najjar SM, Yang Y, Fernstrom MA, Lee SJ, Deangelis AM, Rjaily GA, Al-Share QY, Dai T, Miller TA, Ratnam S, Ruch RJ, Smith S, Lin SH, Beauchemin N, Oyarce AM, Cell Metabolism, 7/1/2005
• Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice  
  Dai T, Abou-Rjaily GA, Al-Share' QY, Yang Y, Fernstrom MA, Deangelis AM, Lee AD, Sweetman L, Amato A, Pasquali M, Lopaschuk GD, Erickson SK, Najjar SM, J Biol Chem, 10/1/2004
• Effect of cocoa extract on fertility in male rats  
  Dai T, Wu WP, and Wang YN, Guo Wai Yi Xue (Foreign Medicine), 3/1/1993
• Join now to see all

Books/Book Chapters

• Chemoradiation in oesophageal cancer 
  Chapter: Best Practice & Research Clinical Gastroenterology-Barrett’s Oesophagus 
  Page 193 - 209Tong Dai; Manish ShahEditors: David A. Katzka and Prateek Sharma.ELSEVIER2015
• American Association for Cancer Research 100th Annual Meeting Educational Book; Apr 18-22, Denver, CO. 
  Chapter: Notch signaling and cancer. 
  Page 71 - 79Dai TAACR, Philadelphia, PA2009

Abstracts/Posters

• A case of malignant nerve sheath tumor presenting as metastatic cancer.
  Dai T, American College of Physicians, Connecticut Chapter, 1/1/2009
• Role of CEACAM2 in Insulin Action.
  Schroeder-Gloeckler JM, DeAngelis AM, Dai T, Heinrich G, Al-Share QY, et al, American Diabetes Association, Chicago, IL, 1/1/2007
• Differential role of CEACAM proteins in regulating insulin action.
  Dai T, Kim H-J, Fernstrom MA, Park S-Y, Shulman GI, Kim JK, and Najjar SM, ADA Late-breaking Abstract, New Orleans, LA, 1/1/2003
• A novel CEACAM1-dependent down-regulatory role for insulin on fatty acid synthase in liver.
  Yang Y, Dai T, Lin S-H, Beauchemin N, Najjar SM, Endocrine Society Annual Meeting, Philadelphia, PA, 1/1/2003
• A molecular link between fat metabolism and insulin clearance.
  Yang Y, Dai T, Poy MN, Fernstrom MA and Najjar SM, FASEB, 1/1/2002
• Functional Analysis of CEACAM2 in vivo.
  Dai T, Poy MN, and Najjar SM, Endocrinology, 1/1/2001
• CEACAM1 (pp120) binding to fatty acid synthase (FAS): a novel signaling mechanism of regulating insulin clearance.
  Yang Y, Dai T, Poy MN, and Najjar SM, Endocrinology, 1/1/2001
• L-Carnitine restores insulin clearance in S503A CEACAM1 (pp120) mice.
  Dai T, Poy MN, and Najjar SM, The FASEB Journal, 1/1/2001
• Join now to see all

Lectures

• Notch Signaling and Cancer. 
  Denver, CO - 1/1/2009